Seminars in Nephrology
Volume 25, Issue 6 , Pages 397-403 , November 2005

Erythropoietin in Heart Failure

  • Donald S. Silverberg

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    • Corresponding Author InformationAddress reprint requests to Donald S. Silverberg, MD, Department of Nephrology, Tel Aviv Sourasky Medical Center, Weizman 6, Tel Aviv 64239, Israel.
    • ,
  • Dov Wexler

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    • ,
  • Miriam Blum

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    • ,
  • Adrian Iaina

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    • ,
  • David Sheps

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    • ,
  • Gad Keren

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    • ,
  • Doron Schwartz

      Affiliations

    • Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    • Department of Cardiology and Heart Failure Clinic, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

References 

  1. Miller LW , Missov ED . Epidemiology of heart failure . Cardiol Clin . 2001;19:547–555
  2. Cowie MR , Mosterd A , Wood DA , et al.   The epidemiology of heart failure . Eur Heart J . 1997;18:208–225
  3. McMurray JJV , Stewart S . The burden of heart failure . Eur Heart J . 2002;4(suppl D):D50–D58
  4. Jessup M , Brozena S . Heart failure . N Engl J Med . 2003;348:2007–2118
  5. Levy D , Kenchaiah S , Larson MG , et al.   Long term trends in the incidence of and survival with heart failure . N Engl J Med . 2002;347:1397–1402
  6. Silverberg DS , Wexler D , Blum M , et al.   The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations . J Am Coll Cardiol . 2000;35:1737–1744
  7. Silverberg DS , Wexler D , Iaina A . The role of anemia in the progression of Congestive Heart Failure. Is there a place for erythropoietin and intravenous iron? . J Nephrology . 2004;17:749–761
  8. Silverberg DS , Wexler D , Blum M , et al.   Erythropoietin should be part of congestive heart failure management . Kidney Int . 2003;64(suppl 87):S40–S47
  9. Silverberg DS , Wexler D , Blum M , et al.   The interaction between heart failure, renal failure and anemia—the cardio-renal anemia syndrome . Blood Purif . 2004;22:277–284
  10. Butler J , Forman DE , Abraham WT , et al.   Relationship between heart failure treatment and development of worsening renal function among hospitalized patients . Am Heart J . 2004;147:331–338
  11. McClellan WM , Langston RD , Presley R . Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease . J Am Soc Nephrol . 2004;15:1912–1919
  12. Gouva C , Nikolopoulos P , Ioannidis JPA , et al.   Treating anemia early in renal failure slows the decline of renal function (A randomized controlled study) . Kidney Int . 2004;66:753–760
  13. Hillege HL , van Gilst WH , van Veldhuisen DJ , et al.   Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition (The CATS randomized trial) . Eur J Heart Fail . 2003;24:412–420
  14. Ljungman S , Jaragh JH , Cody RJ . Role of the kidney in congestive heart failure (Relationship of cardiac index to kidney function) . Drugs . 1990;39(suppl 4):10–21
  15. Fine L , Dandyopadhay D , Norman JT . Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia . Kidney Int . 2000;57(suppl 75):S22–S26
  16. Klarenbach S , Stafinski T , Longobardi T , et al.   The effect of renal insufficiency on workforce participation in the United States (An analysis using National Health and Nutrition Examination Survey III data) . Am J Kidney Dis . 2002;40:1132–1137
  17. Avorn J , Bohn RL , Levy E , et al.   Nephrologist care and mortality in patients with chronic renal insufficiency . Arch Intern Med . 2002;162:2002–2006
  18. Perry HM , Miller JO , Fornoff JR , et al.   Early predictors of 15 year end stage renal disease in hypertensive patients . Hypertension . 1995;25:587–594
  19. Levin A , Djurdjev O , Barrett B , et al.   Cardiovascular disease in patients with chronic kidney disease (Getting to the heart of the matter) . Am J Kidney Dis . 2001;38:1398–1407
  20. Hebert PC , Van der Linden P , Biro G , et al.   Physiologic aspects of anemia . Crit Care Clin . 2004;20:187–212
  21. Spahn DR , Dettori N , Kocian R , et al.   Transfusion in the cardiac patient . Crit Care Clin . 2004;20:269–279
  22. Wahr JA . Myocardial ischemia in anaemic patients . Br J Anaesth . 1998;81(suppl):10–15
  23. Kobayashi H , Smith CE , Fouad-Tarazi FM , et al.   Circulatory effects of acute normovalemic haemodilution in rats with acute myocardial infarction . Cardiovasc Res . 1989;23:842–851
  24. Anand IS , Chandrashekhar Y , Ferrari R , et al.   Pathogenesis of edema in chronic anemia (Studies of body water and sodium, renal function, haemodynamics and plasma hormones) . Heart . 1993;70:357–362
  25. Siems WG , Sommerburg O , Grune T . Erythrocyte free radical and energy formation . Clin Nephrol . 2000;53(suppl 1):S9–S17
  26. Grune T , Sommerburg O , Siems WG . Oxidative stress in anemia . Clin Nephrol . 2000;53(suppl 1):S18–S22
  27. Silverberg DS , Wexler D , Sheps D , et al.   The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron (A randomized controlled study) . J Am Coll Cardiol . 2001;37:1775–1780
  28. Silverberg DS , Wexler D , Blum M , et al.   The effect of correction of anemia in diabetic and non diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron . Nephrol Dial Transplant . 2003;18:141–146
  29. Mancini DM , Katz SD , Lang C , et al.   Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure . Circulation . 2003;107:294–299
  30. Novak B , Sumodi V , Bynane M , et al.   Anemia management in an outpatient heart failure center . J Cardiac Fail . 2003;9(suppl 1):386; (abstr)
  31. Delgado RM , Radovancevic R , van Rossem CC , et al.   Effect of administration of recombinant human erythropoietin in heart failure patients . Eur Heart J . 2004;25(suppl):2965; (abstr)
  32. Wu W-C , Rathore SS , Wang Y , et al.   Blood transfusion in elderly patients with acute myocardial infarction . N Engl J Med . 2001;345:1230–1236
  33. Nikolsky E , Aymong ED , Halkin A , et al.   Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention . J Am Coll Cardiol . 2004;44:547–553
  34. Langston RD , Presley R , Flanders WD , et al.   Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction . Kidney Int . 2003;64:1398–1405
  35. Reinecke H , Trey T , Wellmann J , et al.   Hemoglobin-related mortality in patients undergoing percutaneous coronary interventions . Eur Heart J . 2003;24:2142–2150
  36. McKechnie RS , Smith D , Montoye C , et al.   Prognostic implication of anaemia on in-hospital outcomes after percutaneous coronary intervention . Circulation . 2004;110:271–277
  37. Gurm HS , Lincoff AM , Kleiman NS , et al.   Double jeopardy of renal insufficiency and anaemia in patients undergoing percutaneous coronary interventions . Am J Cardiol . 2004;94:30–34
  38. Arant CB , Wessel TR , Olson MB , et al.   Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain . J Am Coll Cardiol . 2004;43:2009–2114
  39. Lee PC , Kini AS , Ahsan C , et al.   Anemia is an independent predictor of mortality after percutaneous coronary intervention . J Am Coll Cardiol . 2004;44:541–546
  40. Levin A , Djudjev O , Duncan J , et al.   Hemoglobin levels prior to therapy predict survival in chronic kidney disease (CKD) patients . Nephrol Dial Transplant . 2003;18(suppl 4):T358A
  41. Herzog CA , Muster HA , Li S , et al.   Impact of Congestive Heart Failure, Chronic Kidney Disease and Anemia on survival in the medicare population . J Cardiac Failure . 2004;10:467–472
  42. Jurkovitz CT , Abramson JL , Vaccarino V , et al.   Association of high serum creatinine and anemia increases the risk of coronary events (Results from the prospective community-based Atherosclerosis Risk in Communities (ARIC) study) . J Am Soc Nephrol . 2003;14:2919–2925
  43. Abramson JL , Jurkovitz CT , Vaccarino C , et al.   Chronic kidney disease, anemia and incident stroke in a middle-aged, community based population (The ARIC study) . Kidney Int . 2003;64:610–615
  44. St Peter WL , Xue J , Ebben J , et al.   Pre-end stage renal disease erythropoietin use predicts hospitalization in the periods before and after end-stage renal disease diagnosis . J Am Soc Nephrol . 2001;12(suppl):1274; (abstr)
  45. Collins AJ . Anaemia management prior to dialysis (Cardiovascular benefits and cost-benefit observations) . Nephrol Dial Transplant . 2003;18(suppl 2):ii2–ii6
  46. Valderabano F , Horl W , Macdougall IC , et al.   PRE-dialysis survey on anemia management . Nephrol Dial Transplant . 2003;18:89–100
  47. Xue JL , St Peter WL , Ebben JP , et al.   Anemia treatment in the pre-ESRD period and associated mortality in elderly patients . Am J Kidney Dis . 2002;40:1153–1161
  48. Fink JC , Blahut SA , Reddy M , et al.   Use of erythropoietin before the initiation of dialysis and its impact on mortality . Am J Kidney Dis . 2001;37:348–355
  49. Collins AJ . Influence of target hemoglobin in dialysis patients on morbidity and mortality . Kidney Int . 2002;61(suppl 80):S44–S48
  50. Ofstun N , LaBrecque J , Lacson E , et al.   The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients . Kidney Int . 2003;63:1908–1914
  51. Keane WF , Brenner BM , de Zeeuw D , et al.   The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy (The RENAAL Study) . Kidney Int . 2003;63:1499–1507
  52. van der Meer P , Voors AA , Lipsic E , et al.   Prognostic value of plasma erythropoietin in patients with chronic heart failure . J Am Coll Cardiol . 2004;44:63–67
  53. Thomas MC , MacIsaac RJ , Tsalamandris C , et al.   Unrecognized anemia in patients with diabetes . Diabetes Care . 2003;26:1164–1169
  54. Bosman DR , Winkler AS , Marsden JT , et al.   Anemia with erythropoietin deficiency occurs early in diabetic nephropathy . Diabetes Care . 2001;24:495–499
  55. Iverson PO , Woldbaek PR , Tonnessen T , et al.   Decreased hematopoiesis in bone marrow of mice with congestive heart failure . Am J Physiol . 2002;282:R166–R172
  56. Means RT . Advances in the anemia of chronic disease . Int J Hematol . 1999;70:7–12
  57. Means RT . Hepeidin and anaemia . Blood Reviews . 2004;18:219–225
  58. Bolger AP , Doehner W , Sharma R , et al.   Anemia in chronic heart failure (The relationship to inflammatory cytokine production and prognostic importance) . Circulation . 2002;106(suppl):2819A; (abstr)
  59. Ishani A , Weinhandl E , Zhao Z , et al.   Angiotensin-Converting Enzyme Inhibitor as a risk factor for the development of anemia and the impact of incident anemia on mortality in patients with left ventricular dysfunction . J Am Coll Cardiol . 2005;45:391–399
  60. Matsouka C , Karageorgopoulos D , Tsagalou E , et al.   Etiology of anemia in congestive heart failure . Eur J Heart Fail . 2004;3(suppl):342A; (abstr)
  61. Gotloib L , Ludicer H , Mines M , et al.   Iron storage in chronic uremic undialysed patients . Dial Transplant . 1983;12:442B–442E
  62. Schustack A , Meshiaj D , Waiss D , et al.   Intramuscular iron replenishment and replacement combined with testosterone enanthate in maintenance hemodialysis (A follow up of 8 years on 16 patients) . Clin Nephrol . 1985;23:303–306
  63. Anker SD , Sharma R . The syndrome of cardiac cachexia . Int J Cardiol . 2002;85:51–66
  64. Vaziri ND . Erythropoietin and transferrin metabolism in nephrotic syndrome . Am J Kidney Dis . 2001;38:1–8
  65. Kooistra MP , Niemantsverdriet EC , van Es A , et al.   Iron absorption in erythropoietin-treated haemodialysis patients (Effects of iron availability, inflammation and aluminum) . Nephrol Dial Transplant . 1998;13:82–88
  66. Ryan E , Ledwidge MT , McDonald K . Anaemia in a heart failure disease management program (iron deficiency or anaemia of chronic disease?) . Eur Heart J . 2003;24(suppl):P3254
  67. Silverberg DS , Iaina A , Peer G , et al.   Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis . Am J Kidney Dis . 1996;27:234–238
  68. Silverberg DS , Blum M , Agbaria Z , et al.   The effect of IV iron alone or in combination with low dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period . Clin Nephrol . 2001;55:212–219
  69. Androne AS , Katz SD , Lund L , et al.   Hemodilution is common in patients with advanced heart failure . Circulation . 2003;107:226–229
  70. van der Meer P , Voors AA , Lipsic E , et al.   Erythropoietin in cardiovascular diseases . Eur Heart J . 2004;25:285–291
  71. Calvillo L , Latini R , Kajstura J , et al.   Recombinant human erythropoietin protects the myocardium from ischemia-perfusion injury and promotes beneficial remodeling . Proceedings of the National Academy of Sciences (PNAS) . 2003;100:4802–4806
  72. Ehrenreich H , Hasselblatt M , Dembowski C , et al.   Erythropoietin therapy for acute stroke is both safe and beneficial . Mol Med . 2002;8:495–505

PII: S0270-9295(05)00104-X

doi: 10.1016/j.semnephrol.2005.05.009

Seminars in Nephrology
Volume 25, Issue 6 , Pages 397-403 , November 2005

Article Tools